Cargando…
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
[Image: see text] Structure–activity relationship translation offers an expeditious means for discovery of new active series. This approach was applied to discover tetrahydroisoquinoline (THIQ)-based steroidomimetic microtubule disruptors. The two A-ring elements of a three-point steroidal pharmacop...
Autores principales: | Leese, Mathew P., Jourdan, Fabrice, Dohle, Wolfgang, Kimberley, Meriel R., Thomas, Mark P., Bai, Ruoli, Hamel, Ernest, Ferrandis, Eric, Potter, Barry V. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2011
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256937/ https://www.ncbi.nlm.nih.gov/pubmed/22247790 http://dx.doi.org/10.1021/ml200232c |
Ejemplares similares
-
Synthesis, Anti-tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones
por: Leese, Mathew P, et al.
Publicado: (2014) -
Tetrahydroisoquinoline Sulfamates as Potent Microtubule
Disruptors: Synthesis, Antiproliferative and Antitubulin Activity
of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure
por: Dohle, Wolfgang, et al.
Publicado: (2019) -
Cell Fate following Irradiation of MDA-MB-231 and MCF-7 Breast Cancer Cells Pre-Exposed to the Tetrahydroisoquinoline Sulfamate Microtubule Disruptor STX3451
por: Hargrave, Scott D., et al.
Publicado: (2022) -
Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines
por: Nel, Marcel, et al.
Publicado: (2018) -
The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers
por: Newman, S P, et al.
Publicado: (2007)